2nd Quarter - Report
GRASSROOTS POLITICAL CONSULTING LLC for REVIVE THERAPEUTICS INC.
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocating for assistance w/Phase 3 trial for Bucillamine, educating Members of Congress, BARDA/HHS and NIH regarding Bucillamine as a repurposed drug for COVID19.
Foreign entity interest: Canadian company listed on CSE
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL FARACI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.